$2.15-0.09 (-4.02%)
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.
Intelligent Bio Solutions Inc. in the Healthcare sector is trading at $2.15 with a market capitalization of $7M. Wall Street consensus targets $12.00 (1 analysts), implying a +458.1% move over the next 12 months. The stock is currently near its 52-week low of $1.52, remaining 50.8% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 14 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.06Mβ | $896,774β | $1.11Mβ | $843,884β | $728,867 |
| Gross Profit | $535,381β | $459,739β | $518,291β | $335,577β | $341,368 |
| Operating Income | -$2.94Mβ | -$2.61Mβ | -$2.74Mβ | -$2.88Mβ | -$2.56M |
| Net Income | -$2.86Mβ | -$2.68Mβ | -$2.98Mβ | -$3.09Mβ | -$2.54M |
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelli...